Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We recently showed that mutation of the VPS35 gene can cause late-onset
Parkinson's disease
. In the present study we sequenced 702 affected subjects from the Mayo Clinic
Parkinson's disease
patient-control series for the
VPS29
and VPS26A/B genes. We identified only 2 rare nonsynonymous variants in the VPS26A p.K93E and
VPS29
p.N72H. The results show that mutations in the genes composing the retromer cargo recognition subunit are not a common cause of
Parkinson's disease
.
...
PMID:Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease. 2468 91
The retromer complex is a vital component of the endosomal protein sorting machinery necessary for sorting into both the endosome-to-Golgi retrieval pathway and also the endosome-to-cell-surface recycling pathway. Retromer mediates cargo selection through a trimeric complex comprising VPS35,
VPS29
and VPS26, which is recruited to endosomes by binding to Rab7a and Snx3. Retromer function is linked to two distinct neurodegenerative diseases,
Parkinson's disease
and Alzheimer's disease and modulating retromer function has been proposed as an avenue to explore for a putative therapy in these conditions. We hypothesised that activating Rab7a to promote the recruitment of retromer to endosomes could positively modulate its activity. Here, we show that inhibition of the GTPase activating protein TBC1D5 can enhance Rab7a activation and lead to a gain of function for retromer.
...
PMID:Inhibition of TBC1D5 activates Rab7a and can enhance the function of the retromer cargo-selective complex. 2977 37